SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-008657
Filing Date
2022-01-13
Accepted
2022-01-13 16:04:03
Documents
12
Period of Report
2022-01-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d287345d8k.htm   iXBRL 8-K 27852
  Complete submission text file 0001193125-22-008657.txt   153668

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA svra-20220113.xsd EX-101.SCH 2904
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20220113_lab.xml EX-101.LAB 18908
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20220113_pre.xml EX-101.PRE 11871
6 EXTRACTED XBRL INSTANCE DOCUMENT d287345d8k_htm.xml XML 3518
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 22529118
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences